Clinical Trials Directory

Trials / Completed

CompletedNCT04310813

Microscopic-spectroscopic Examination for Urothelial Tissue Characterization

Status
Completed
Phase
Study type
Observational
Enrollment
114 (actual)
Sponsor
Careggi Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To evaluate the possibility to properly discriminate between healthy bladder tissue and BCa with a multimodal fiber optic spectroscopy (MFOS) technique, in order to possibly introduce a more objective way to detect BCa, thus reducing inter-observer variability and maybe to determine urothelial carcinoma stage and grade with a comparable accuracy, specificity and sensibility of the current gold standard histopathological analysis

Detailed description

Observational single center study on human biological samples to evaluate the possibility to discriminate between healthy and tumor tissue on urothelial bladder samples. Aim of the study is to provide a fast, reliable and label free aid/alternative to current histopathology

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMultimodal spectroscopic analysisDuring time of bladder or prostate resection, freshly excised cold cup biopsies of both bladder cancer or healthy bladder mucosa were taken and sent for inspection through label-free multimodal fiber optic spectroscopy (MFOS) within 30 minutes

Timeline

Start date
2016-11-01
Primary completion
2019-12-01
Completion
2020-03-01
First posted
2020-03-17
Last updated
2020-03-18

Source: ClinicalTrials.gov record NCT04310813. Inclusion in this directory is not an endorsement.